6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine, 95.0%, 100mg

Filtration unit Stericup® with Durapore® (PVDF) membrane Pore size 0.22 μm, 500 ml, 500 ml, 12 Piece(s)

N-(5-Chloro-2-methylphenyl)methanesulfonamide, 95%, 1g

[(3-tert-butyl-1,2,4-oxadiazol-5-yl)methyl]amine hydrochloride, 95.0%, 5g

N2,9-Diacetylguanine>95.0%(T)25g

METHYL 6,6-DIFLUOROBICYCLO[3.1.0]HEXANE-3-CARBOXYLATE, 95.0%, 500mg

Cyclopentanecarboxylic acid, 97.0%, 1g

N-(4-Bromo-2-nitrophenyl)acetamide, 95.0%, 5g

Syringe filters ROTILABO® PVDF, 0,45 µm, 30 mm, 100 Piece(s)

(R)-2-Amino-4,4-dimethylpentan-1-ol hydrochloride, 98%, 1g

2-(1H-Indol-5-yl)acetonitrile, 95.0%, 100mg

5-Bromo-4-methylnicotinaldehyde, 95.0%, 250mg

4-Chloro-1,2-diaminobenzene, 95.0%, 25g